Clinical Trial Update: Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adapted chemotherapy for head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Cancer of Head and Neck | Phase 2 | Status: COMPLETED